The present invention relates to a formulation in the form of a lozenge comprising an endothermic cooling agent selected from the group consisting of xylitol, sorbitol, mannitol and erythritol having a heat of enthalpy between -10cal/g and -100cal/g, and one or more active agents wherein the endothermic agent is present in the formulation at an amount less than 10% w/w.